← All organizations

APCER Life Sciences

Academic/Hospital

Also known as: APCER | APCER Life Sciences

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 31, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

obiltoxaximab

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

etripamil

Indications

Studied for

Recent trials (4)

NCT03088111CollaboratorPhase 4Dec 31, 2023
NCT04467905CollaboratorPhase 2Nov 19, 2020
NCT03202147CollaboratorPhase 2Jul 1, 2016
NCT02547818CollaboratorPhase 3Sep 1, 2015

Details

Last known activity: Dec 31, 2023